OH2 Injection in Melanoma

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
To evaluate the efficacy of OH2 injection in patients with unresectable or metastatic melanoma who have failed at least second-line standard therapy, using investigator-selected salvage chemotherapy or best supportive care (BSC) as controls.
Epistemonikos ID: 7e817d9f478fcc79671bebffa79b99232f8d4bdf
First added on: Feb 19, 2024